DrugPatentWatch Database Preview
BYNFEZIA PEN Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Bynfezia Pen patents expire, and what generic alternatives are available?
Bynfezia Pen is a drug marketed by Sun Pharm and is included in one NDA. There is one patent protecting this drug.
This drug has four patent family members in four countries.
The generic ingredient in BYNFEZIA PEN is octreotide acetate. There are twenty drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the octreotide acetate profile page.
US ANDA Litigation and Generic Entry Outlook for Bynfezia Pen
A generic version of BYNFEZIA PEN was approved as octreotide acetate by WEST-WARD PHARMS INT on April 8th, 2005.
Summary for BYNFEZIA PEN
| International Patents: | 4 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | BYNFEZIA PEN at DailyMed |
Pharmacology for BYNFEZIA PEN
| Drug Class | Somatostatin Analog |
| Mechanism of Action | Somatostatin Receptor Agonists |
US Patents and Regulatory Information for BYNFEZIA PEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharm | BYNFEZIA PEN | octreotide acetate | SOLUTION;SUBCUTANEOUS | 213224-001 | Jan 28, 2020 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for BYNFEZIA PEN
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20200003923 | Start Trial |
| European Patent Office | 3624829 | Start Trial |
| China | 110678194 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
